Daniel Werb

Title(s)Associate Adjunct Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Preventing HIV by modifying the context for injecting initiation
    NIH DP2DA040256Jul 1, 2015 - Jun 30, 2020
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Motivations for and perspectives of medication diversion among clients of a safer opioid supply program in Toronto, Canada. Int J Drug Policy. 2024 Dec 04; 135:104665. Martignetti L, Knight R, Nafeh F, Atkinson K, Laurence G, Johnson CH, Werb D, Karamouzian M. PMID: 39637492.
      View in: PubMed   Mentions:
    2. Frequency of supervised consumption service use and acute care utilization in people who inject drugs. Drug Alcohol Depend. 2024 Nov 08; 265:112490. Scheim AI, Bouck Z, Greenwald ZR, Ling V, Hopkins S, Johnson M, Bayoumi A, Gomes T, Werb D. PMID: 39546979.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA. Int J Drug Policy. 2024 Oct; 132:104557. Killion JA, Jegede OS, Werb D, Davidson PJ, Smith LR, Gaines T, Graff Zivin J, Zúñiga ML, Pines HA, Garfein RS, Strathdee SA, Rivera Saldana C, Martin NK. PMID: 39213827.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. A cross-sectional assessment of injection of "salts" and HIV transmission-related behaviours among a cohort of people who inject drugs in Kyrgyzstan. J Int AIDS Soc. 2024 Jul; 27(7):e26247. Kennedy R, Bouck Z, Werb D, Kurmanalieva A, Blyum A, Shumskaya N, Patterson TL, Cepeda JA, Smith LR. PMID: 38978392; PMCID: PMC11231446.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis. Harm Reduct J. 2024 05 16; 21(1):94. Mitra S, Bouck Z, Larney S, Zolopa C, Høj S, Minoyan N, Upham K, Rammohan I, Mok WY, Hayashi K, Milloy MJ, DeBeck K, Scheim A, Werb D. PMID: 38750575; PMCID: PMC11097551.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    6. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives. Harm Reduct J. 2024 05 11; 21(1):92. Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, Arnold EA. PMID: 38734643; PMCID: PMC11088080.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada. J Clin Epidemiol. 2024 Jun; 170:111332. Greenwald ZR, Werb D, Feld JJ, Austin PC, Fridman D, Bayoumi AM, Gomes T, Kendall CE, Lapointe-Shaw L, Scheim AI, Bartlett SR, Benchimol EI, Bouck Z, Boucher LM, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC. PMID: 38522754.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024 Feb; 9(2):e79-e87. Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. PMID: 38307685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Flawed reports can harm: the case of supervised consumption services in Alberta. Can J Public Health. 2023 12; 114(6):928-933. Salvalaggio G, Brooks H, Caine V, Gagnon M, Godley J, Houston S, Kennedy MC, Kosteniuk B, Livingston J, Saah R, Speed K, Urbanoski K, Werb D, Hyshka E. PMID: 37930628; PMCID: PMC10661131.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts. J Subst Use Addict Treat. 2024 02; 157:209185. Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G. PMID: 37865289.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Young, Black/African American, and Latino communities are left behind despite legislative efforts in California to reduce HIV/STI disparities. Front Reprod Health. 2023; 5:1179334. Gaines TL, Werb D, Harris O. PMID: 37779638; PMCID: PMC10538965.
      View in: PubMed   Mentions: 1  
    12. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis. Int J Drug Policy. 2023 Oct; 120:104157. Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D. PMID: 37574645.
      View in: PubMed   Mentions: 6     Fields:    
    13. Stigma is stopping an evidence based response to drug overdose deaths in the UK. BMJ. 2023 08 09; 382:e074934. Guise A, Harris M, McCusker M, McNeil R, Werb D. PMID: 37558236.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Financial Vulnerability and Its Association with HIV Transmission Risk Behaviors Among People Who Inject Drugs in Kyrgyzstan. AIDS Behav. 2024 Jan; 28(1):310-319. Algarin AB, Werb D, Shumskaya N, Kurmanalieva A, Blyum A, Cepeda J, Patterson TL, Baral S, Smith LR. PMID: 37523049; PMCID: PMC11376237.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Context and correlates of providing assistance with someone's first injection in the AIDS linked to the IntraVenous Experience cohort, Baltimore, MD. Drug Alcohol Depend. 2023 09 01; 250:110909. Gicquelais RE, Astemborski J, Werb D, Kirk GD, Mehta SH, Genberg BL. PMID: 37517262; PMCID: PMC10529208.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Latent polydrug use patterns and the provision of injection initiation assistance among people who inject drugs in three North American settings. Drug Alcohol Rev. 2023 09; 42(6):1504-1516. Rammohan I, Jain S, Sun S, Marks C, Milloy MJ, Hayashi K, DeBeck K, González-Zúñiga P, Strathdee S, Werb D. PMID: 37321850; PMCID: PMC10524861.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. "2.5 g, I could do that before noon": a qualitative study on people who use drugs' perspectives on the impacts of British Columbia's decriminalization of illegal drugs threshold limit. Subst Abuse Treat Prev Policy. 2023 06 15; 18(1):32. Ali F, Russell C, Greer A, Bonn M, Werb D, Rehm J. PMID: 37322496; PMCID: PMC10268332.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs. Int J Environ Res Public Health. 2023 05 30; 20(11). Ondocsin J, Ciccarone D, Moran L, Outram S, Werb D, Thomas L, Arnold EA. PMID: 37297603; PMCID: PMC10252652.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    19. First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada. Drug Alcohol Depend Rep. 2023 Jun; 7:100168. Bouck Z, Tricco AC, Rosella LC, Banack HR, Fox MP, Platt RW, Milloy MJ, DeBeck K, Hayashi K, Werb D. PMID: 37397436; PMCID: PMC10311194.
      View in: PubMed   Mentions:
    20. Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic. Drug Alcohol Depend Rep. 2023 Jun; 7:100167. Bowles JM, Kolla G, Smith LR, Scheim A, Dodd Z, Werb D. PMID: 37273749; PMCID: PMC10199487.
      View in: PubMed   Mentions:
    21. The ups and downs of harm reduction in Afghanistan. Lancet Reg Health Southeast Asia. 2023 Jun; 13:100186. Nafeh F, Werb D, Karamouzian M. PMID: 37383551; PMCID: PMC10306026.
      View in: PubMed   Mentions:
    22. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2023 03 03; 18(1):14. Bardwell G, Bowles JM, Mansoor M, Werb D, Kerr T. PMID: 36869358; PMCID: PMC9984129.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis. J Viral Hepat. 2023 02; 30(2):160-171. Greenwald ZR, Bouck Z, McLean E, Mason K, Lettner B, Broad J, Dodd Z, Nassau T, Scheim AI, Werb D. PMID: 36461705.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    24. Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply. Clin Biochem. 2023 Jan; 111:11-16. Delaney SR, Konforte D, Stefan C, Palaty J, Sun D, McDonald K, Thompson H, Werb D, Beriault DR. PMID: 36379241.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    25. Drug checking use and interest among people who inject drugs in Toronto, Canada. Int J Drug Policy. 2022 09; 107:103781. Rammohan I, Bouck Z, Fusigboye S, Bowles J, McDonald K, Maghsoudi N, Scheim A, Werb D. PMID: 35803177.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    26. Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study. Harm Reduct J. 2022 05 25; 19(1):53. Smith LR, Shumskaia N, Kurmanalieva A, Patterson TL, Werb D, Blyum A, Algarin AB, Yeager S, Cepeda J. PMID: 35614508; PMCID: PMC9131652.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance. Subst Abuse Treat Prev Policy. 2022 05 19; 17(1):39. Meyers-Pantele SA, Mittal ML, Jain S, Sun S, Rammohan I, Fairbairn N, Milloy MJ, DeBeck K, Hayashi K, Werb D. PMID: 35590419; PMCID: PMC9118611.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Requiring help injecting among people who inject drugs in Toronto, Canada: Characterising the need to address sociodemographic disparities and substance-use specific patterns. Drug Alcohol Rev. 2022 07; 41(5):1062-1070. Mitra S, Kolla G, Bardwell G, Wang R, Sniderman R, Mason K, Werb D, Scheim A. PMID: 35577755.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada. Clin Toxicol (Phila). 2022 08; 60(8):979-984. Scarfone KM, Maghsoudi N, McDonald K, Thompson H, Stefan C, Beriault DR, Werb D, Bowles JM. PMID: 35546568.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Health harms of non-medical prescription opioid use: A systematic review. Drug Alcohol Rev. 2022 05; 41(4):941-952. Werb D, Scheim AI, Soipe A, Aeby S, Rammohan I, Fischer B, Hadland SE, Marshall BDL. PMID: 35437841; PMCID: PMC9064965.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Measurement of public health impacts of cannabis legalization in Canada to reflect policy maker priorities: A rapid scoping review of instruments and content domains. Drug Alcohol Depend. 2022 07 01; 236:109463. Lazor T, Blondal E, Scheim A, Cubillos P, Werb D, Milloy MJ, Bonato S, Maghsoudi N, Rueda S. PMID: 35594643.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    32. Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis. Drug Alcohol Depend. 2022 07 01; 236:109459. Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. PMID: 35489179; PMCID: PMC9008980.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    33. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions. Int J Drug Policy. 2022 06; 104:103680. Bouck Z, Scheim AI, Gomes T, Ling V, Caudarella A, Werb D. PMID: 35447476; PMCID: PMC9005368.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    34. Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada. Harm Reduct J. 2022 03 29; 19(1):33. Nassau T, Kolla G, Mason K, Hopkins S, Tookey P, McLean E, Werb D, Scheim A. PMID: 35351160; PMCID: PMC8966307.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Diversity among health care leaders in Canada: a cross-sectional study of perceived gender and race. CMAJ. 2022 03 14; 194(10):E371-E377. Sergeant A, Saha S, Lalwani A, Sergeant A, McNair A, Larrazabal E, Yang K, Bogler O, Dhoot A, Werb D, Maghsoudi N, Richardson L, Hawker G, Siddiqi A, Verma A, Razak F. PMID: 35288408; PMCID: PMC8920524.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation. JAMA. 2022 03 01; 327(9):846-855. Gomes T, Campbell TJ, Kitchen SA, Garg R, Bozinoff N, Men S, Tadrous M, Munro C, Antoniou T, Werb D, Wyman J. PMID: 35230394; PMCID: PMC8889466.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    37. Validation of Self-reported Opioid Agonist Treatment Among People Who Inject Drugs Using Prescription Dispensation Records. Epidemiology. 2022 03 01; 33(2):287-294. Bouck Z, Tricco AC, Rosella LC, Ling V, Gomes T, Tadrous M, Fox MP, Scheim AI, Werb D. PMID: 34799473.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis. Int J Drug Policy. 2022 05; 103:103644. Kitchen SA, Campbell TJ, Men S, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. PMID: 35272107; PMCID: PMC8885322.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    39. CMAJ. 2022 01 17; 194(2):E60-E72. Persaud N, Woods H, Workentin A, Adekoya I, Dunn JR, Hwang SW, Maguire J, Pinto AD, O'Campo P, Rourke SB, Werb D, pour le groupe de travail du Centre MAP pour une reprise équitable après la pandémie. PMID: 35039395; PMCID: PMC8900790.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    40. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020. Harm Reduct J. 2022 01 11; 19(1):3. Scarfone KM, Maghsoudi N, McDonald K, Stefan C, Beriault DR, Wong E, Evert M, Hopkins S, Leslie P, Watson TM, Werb D, Toronto’s Drug Checking Service Working Group. PMID: 35012557; PMCID: PMC8748183.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    41. Recommendations for equitable COVID-19 pandemic recovery in Canada. CMAJ. 2021 Dec 13; 193(49):E1878-E1888. Persaud N, Woods H, Workentin A, Adekoya I, Dunn JR, Hwang SW, Maguire J, Pinto AD, O'Campo P, Rourke SB, Werb D, MAP Task Force to Promote Health Equity during Pandemic Recovery. PMID: 37578741; PMCID: PMC8677581.
      View in: PubMed   Mentions: 14     Fields:    
    42. Drug checking services for people who use drugs: a systematic review. Addiction. 2022 03; 117(3):532-544. Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, Scheim AI. PMID: 34729849; PMCID: PMC9299873.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    43. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Harm Reduct J. 2021 10 13; 18(1):104. Bowles JM, McDonald K, Maghsoudi N, Thompson H, Stefan C, Beriault DR, Delaney S, Wong E, Werb D. PMID: 34645480; PMCID: PMC8511847.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    44. Gender and the first-time provision of injection initiation assistance among people who inject drugs across two distinct North American contexts: Tijuana, Mexico and Vancouver, Canada. Drug Alcohol Rev. 2022 03; 41(3):686-696. Meyers-Pantele SA, Jain S, Sun X, Marks C, DeBeck K, Hayashi K, Strathdee SA, Werb D. PMID: 34636100; PMCID: PMC8930605.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico. Int J Drug Policy. 2021 09; 95:103398. Bowles JM, Jain S, Sun X, Strathdee SA, DeBeck K, Milloy MJ, Bouck Z, Werb D. PMID: 34390966; PMCID: PMC8530890.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings. BMJ Open. 2021 08 12; 11(8):e046957. Marks C, Meyers SA, Jain S, Sun X, Hayashi K, Gonzalez-Zuniga P, Strathdee SA, Garfein RS, Milloy MJ, DeBeck K, Cummins K, Werb D. PMID: 34385244; PMCID: PMC8362731.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile. J Urban Health. 2021 08; 98(4):538-550. Scheim AI, Sniderman R, Wang R, Bouck Z, McLean E, Mason K, Bardwell G, Mitra S, Greenwald ZR, Thavorn K, Garber G, Baral SD, Rourke SB, Werb D. PMID: 34181179; PMCID: PMC8237772.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    48. Trends and outcomes of serious complications associated with non-fatal opioid overdoses in Ontario, Canada. Drug Alcohol Depend. 2021 08 01; 225:108830. Kitchen SA, McCormack D, Werb D, Caudarella A, Martins D, Matheson FI, Gomes T. PMID: 34182376.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. The impact of recent homelessness on the provision of injection drug use initiation assistance among persons who inject drugs in Tijuana, Mexico and Vancouver, Canada. Drug Alcohol Depend. 2021 08 01; 225:108829. Marks C, Bouck Z, Jain S, Sun X, Strathdee SA, Vickerman P, DeBeck K, Milloy MJ, Hayashi K, Werb D. PMID: 34237582; PMCID: PMC8827172.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Articulating the Trauma-Informed Theory of Individual Health Behavior. Stress Health. 2022 Feb; 38(1):154-162. Marks C, Pearson JL, Zúñiga ML, Martin N, Werb D, Smith LR. PMID: 34009751; PMCID: PMC9035290.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Reprint of: The regulation project: Tools for engaging the public in the legal regulation of drugs. Int J Drug Policy. 2021 05; 91:103279. Bernstein SE, Amirkhani E, Werb D, MacPherson D. PMID: 34024456; PMCID: PMC9759266.
      View in: PubMed   Mentions: 1     Fields:    
    52. The intersection of gender and drug use-related stigma: A mixed methods systematic review and synthesis of the literature. Drug Alcohol Depend. 2021 06 01; 223:108706. Meyers SA, Earnshaw VA, D'Ambrosio B, Courchesne N, Werb D, Smith LR. PMID: 33901753; PMCID: PMC8168566.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    53. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings. Drug Alcohol Rev. 2021 05; 40(4):580-585. Ti L, Tobias S, Maghsoudi N, Milloy MJ, McDonald K, Shapiro A, Beriault D, Stefan C, Lysyshyn M, Werb D. PMID: 33354869.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    54. Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada. Int J Drug Policy. 2021 01; 87:102993. Scheim AI, Bouck Z, Tookey P, Hopkins S, Sniderman R, McLean E, Garber G, Baral S, Rourke SB, Werb D. PMID: 33160158.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. The role of drug treatment and recovery services: an opportunity to address injection initiation assistance in Tijuana, Mexico. Subst Abuse Treat Prev Policy. 2020 10 12; 15(1):78. Meyers SA, Rafful C, Jain S, Sun X, Skaathun B, Guise A, Gonzalez-Zuñiga P, Strathdee SA, Werb D, Mittal ML. PMID: 33046125; PMCID: PMC7552370.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. The regulation project: Tools for engaging the public in the legal regulation of drugs. Int J Drug Policy. 2020 Oct 10; 86:102949. Bernstein SE, Amirkhani E, Werb D, MacPherson D. PMID: 33049592; PMCID: PMC7547323.
      View in: PubMed   Mentions: 2     Fields:    
    57. Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review. BMJ Open. 2020 09 21; 10(9):e035148. Scheim AI, Maghsoudi N, Marshall Z, Churchill S, Ziegler C, Werb D. PMID: 32958480; PMCID: PMC7507857.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    58. Self-perception of assisting with future injection drug initiation: The influence of relationships in the process of drug injecting initiation. Drug Alcohol Rev. 2021 01; 40(1):109-117. Bloom BE, Jain S, Sun X, Garfein RS, Strathdee SA, Milloy MJ, Hayashi K, DeBeck K, Bluthenthal R, Werb D, Rafful C. PMID: 32840027; PMCID: PMC7977721.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Preventing transitions into injection drug use: A call for gender-responsive upstream prevention. Int J Drug Policy. 2020 09; 83:102836. Meyers SA, Smith LR, Werb D. PMID: 32679459; PMCID: PMC7793169.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    60. Recent incarceration and risk of first-time injection initiation assistance: A prospective cohort study of persons who inject drugs. Drug Alcohol Depend. 2020 07 01; 212:107983. Bouck Z, Jain S, Sun X, Milloy MJ, Werb D, Hayashi K. PMID: 32380374; PMCID: PMC7293943.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada. Can J Public Health. 2020 08; 111(4):606-609. Maghsoudi N, Bowles J, Werb D. PMID: 32221867; PMCID: PMC7438433.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    62. Prevalence and Correlates of Providing and Receiving Assistance With the Transition to Injection Drug Use. Epidemiol Rev. 2020 01 31; 42(1):4-18. Gicquelais RE, Werb D, Marks C, Ziegler C, Mehta SH, Genberg BL, Scheim AI. PMID: 33024995; PMCID: PMC7947591.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    63. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale. Harm Reduct J. 2020 01 28; 17(1):9. Maghsoudi N, McDonald K, Stefan C, Beriault DR, Mason K, Barnaby L, Altenberg J, MacDonald RD, Caldwell J, Nisenbaum R, Leece P, Watson TM, Tupper KW, Kufner L, Scheim AI, Werb D, Drug Checking Services in Toronto Working Group. PMID: 32204713; PMCID: PMC7092475.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    64. Prevalence and Correlates of Injecting with Visitors from the United States Among People Who Inject Drugs in Tijuana, Mexico. J Immigr Minor Health. 2019 Dec; 21(6):1200-1207. Bórquez A, Garfein RS, Abramovitz D, Liu L, Beletsky L, Werb D, Mehta SR, Rangel G, Magis-Rodríguez C, González-Zúñiga P, Strathdee SA. PMID: 30771144; PMCID: PMC6697237.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis. PLoS Med. 2019 11; 16(11):e1002973. Marks C, Borquez A, Jain S, Sun X, Strathdee SA, Garfein RS, Milloy MJ, DeBeck K, Cepeda JA, Werb D, Martin NK. PMID: 31770373; PMCID: PMC6879119.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    66. Drugs, discipline and death: Causes and predictors of mortality among people who inject drugs in Tijuana, 2011-2018. Int J Drug Policy. 2020 01; 75:102601. West BS, Abramovitz DA, Gonzalez-Zuniga P, Rangel G, Werb D, Cepeda J, Beletsky L, Strathdee SA. PMID: 31775080; PMCID: PMC6957706.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    67. The role of gender and power dynamics in injection initiation events within intimate partnerships in the US-Mexico border region. Cult Health Sex. 2020 09; 22(9):1080-1095. Meyers SA, Smith LR, Luisa Mittal M, Strathdee SA, Garfein RS, Guise A, Werb D, Rafful C. PMID: 31625809; PMCID: PMC7771651.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    68. Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada. Drug Alcohol Rev. 2019 09; 38(6):606-621. Lake S, Kerr T, Werb D, Haines-Saah R, Fischer B, Thomas G, Walsh Z, Ware MA, Wood E, Milloy MJ. PMID: 31577059.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    69. "Another Person Was Going to Do It": The Provision of Injection Drug Use Initiation Assistance in a High-Risk U.S.-Mexico Border Region. Subst Use Misuse. 2019; 54(14):2338-2350. Mittal ML, Guise A, Rafful C, Gonzalez-Zuñiga P, Davidson P, Vashishtha D, Strathdee SA, Werb D. PMID: 31389282; PMCID: PMC6883155.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    70. Navigating social norms of injection initiation assistance during an overdose crisis: A qualitative study of the perspectives of people who inject drugs (PWID) in Vancouver, Canada. Int J Drug Policy. 2019 07; 69:24-33. Olding M, Werb D, Guise A, Small W, McNeil R. PMID: 31029914; PMCID: PMC7059802.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study. Int J Drug Policy. 2019 07; 69:16-23. Reddon H, Fast D, DeBeck K, Werb D, Hayashi K, Wood E, Milloy MJ. PMID: 31015080; PMCID: PMC7039539.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    72. Opioid agonist treatment and the process of injection drug use initiation. Drug Alcohol Depend. 2019 04 01; 197:354-360. Mittal ML, Jain S, Sun S, DeBeck K, Milloy MJ, Hayashi K, Hadland SE, Werb D. PMID: 30922483; PMCID: PMC6719710.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    73. Identification of a Syndemic of Blood-Borne Disease Transmission and Injection Drug Use Initiation at the US-Mexico Border. J Acquir Immune Defic Syndr. 2018 12 15; 79(5):559-565. Rafful C, Jain S, Sun X, Strathdee SA, Garfein RS, Cuevas-Mota J, Magis-Rodríguez C, Smith LR, Werb D. PMID: 30222661; PMCID: PMC6231973.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    74. Gender differences in the provision of injection initiation assistance: a comparison of three North American settings. Harm Reduct J. 2018 12 04; 15(1):59. Meyers SA, Scheim A, Jain S, Sun X, Milloy MJ, DeBeck K, Hayashi K, Garfein RS, Werb D. PMID: 30514384; PMCID: PMC6280353.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border. Am J Public Health. 2019 01; 109(1):73-82. Goodman-Meza D, Medina-Mora ME, Magis-Rodríguez C, Landovitz RJ, Shoptaw S, Werb D. PMID: 30495992; PMCID: PMC6301408.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    76. The global health and equity imperative for safe consumption facilities. Lancet. 2018 08 18; 392(10147):553-554. Beletsky L, Baker P, Arredondo J, Emuka A, Goodman-Meza D, Medina-Mora ME, Werb D, Davidson P, Amon JJ, Strathdee S, Magis-Rodriguez C. PMID: 30152386.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    77. Integrating supervised consumption into a continuum of care for people who use drugs. CMAJ. 2018 08 07; 190(31):E921-E922. Scheim A, Werb D. PMID: 30087127; PMCID: PMC6078768.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico. Harm Reduct J. 2018 05 18; 15(1):27. Ospina-Escobar A, Magis-Rodríguez C, Juárez F, Werb D, Bautista Arredondo S, Carreón R, Ramos ME, Strathdee S. PMID: 29776368; PMCID: PMC5960140.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    79. A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Int J Drug Policy. 2018 05; 55:51-60. Guise A, Melo J, Mittal ML, Rafful C, Cuevas-Mota J, Davidson P, Garfein RS, Werb D. PMID: 29524733; PMCID: PMC5970953.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    80. Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction. 2018 06; 113(6):1056-1063. Rafful C, Orozco R, Rangel G, Davidson P, Werb D, Beletsky L, Strathdee SA. PMID: 29333664; PMCID: PMC5938130.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    81. Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico. J Urban Health. 2018 02; 95(1):83-90. Ben Hamida A, Rafful C, Jain S, Sun S, Gonzalez-Zuniga P, Rangel G, Strathdee SA, Werb D. PMID: 28815465; PMCID: PMC5862694.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    82. Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. J Urban Health. 2018 02; 95(1):91-98. Werb D, Bluthenthal RN, Kolla G, Strike C, Kral AH, Uusküla A, Des Jarlais D. PMID: 28948444; PMCID: PMC5862695.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    83. Injection Drug Use Trajectories among Migrant Populations: A Narrative Review. Subst Use Misuse. 2018 07 29; 53(9):1558-1570. Melo JS, Mittal ML, Horyniak D, Strathdee SA, Werb D. PMID: 29364762; PMCID: PMC6033671.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    84. Cross-border migration and initiation of others into drug injecting in Tijuana, Mexico. Drug Alcohol Rev. 2018 04; 37 Suppl 1:S277-S284. Rafful C, Melo J, Medina-Mora ME, Rangel G, Sun X, Jain S, Werb D. PMID: 29168262; PMCID: PMC5940504.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings. Drug Alcohol Depend. 2018 01 01; 182:67-73. Melo JS, Garfein RS, Hayashi K, Milloy MJ, DeBeck K, Sun S, Jain S, Strathdee SA, Werb D. PMID: 29169035; PMCID: PMC6219752.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    86. History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA. Subst Abuse Treat Prev Policy. 2017 10 03; 12(1):42. Mittal ML, Vashishtha D, Sun S, Jain S, Cuevas-Mota J, Garfein R, Strathdee SA, Werb D. PMID: 28974239; PMCID: PMC5627474.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    87. The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis. Addiction. 2017 Dec; 112(12):2098-2111. Guise A, Horyniak D, Melo J, McNeil R, Werb D. PMID: 28734128; PMCID: PMC5673537.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    88. Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs. Int J Drug Policy. 2018 01; 51:160-164. Werb D. PMID: 28734744; PMCID: PMC6042507.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    89. The North American opioid epidemic: current challenges and a call for treatment as prevention. Harm Reduct J. 2017 05 12; 14(1):7. Vashishtha D, Mittal ML, Werb D. PMID: 28494762; PMCID: PMC5427522.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    90. The effect of incarceration on housing stability among homeless and vulnerably housed individuals in three Canadian cities: A prospective cohort study. Can J Public Health. 2017 03 01; 107(6):e550-e555. To MJ, Palepu A, Matheson FI, Ecker J, Farrell S, Hwang SW, Werb D. PMID: 28252374; PMCID: PMC6972084.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    91. Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego. Int J Drug Policy. 2017 03; 41:132-139. Wood EF, Werb D, Beletsky L, Rangel G, Cuevas Mota J, Garfein RS, Strathdee SA, Wagner KD. PMID: 28111221; PMCID: PMC5342893.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    92. How can we investigate the role of topiramate in the treatment of cocaine use disorder more thoroughly? Addiction. 2017 01; 112(1):182-183. Klimas J, Wood E, Werb D. PMID: 27813211; PMCID: PMC5794002.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. The Spatial-Temporal Pattern of Policing Following a Drug Policy Reform: Triangulating Self-Reported Arrests With Official Crime Statistics. Subst Use Misuse. 2017 01 28; 52(2):214-222. Gaines TL, Werb D, Arredondo J, Alaniz VM, Vilalta C, Beletsky L. PMID: 27767367; PMCID: PMC5378066.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    94. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016 09 15; 13(1):25. Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. PMID: 27629248; PMCID: PMC5024479.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    95. Utilization of Google enterprise tools to georeference survey data among hard-to-reach groups: strategic application in international settings. Int J Health Geogr. 2016 07 28; 15(1):24. Beletsky L, Arredondo J, Werb D, Vera A, Abramovitz D, Amon JJ, Brouwer KC, Strathdee SA, Gaines TL. PMID: 27468764; PMCID: PMC4964042.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    96. Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico. Addiction. 2016 07; 111(7):1246-56. Werb D, Strathdee SA, Vera A, Arredondo J, Beletsky L, Gonzalez-Zuniga P, Gaines T. PMID: 26879179; PMCID: PMC4899159.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    97. A call to reprioritise metrics to evaluate illicit drug policy. Lancet. 2016 Apr 02; 387(10026):1371. Werb D, Kazatchkine M, Kerr T, Nutt D, Strathdee S, Hankins C, Hayashi K, Montaner J, Jarlais DD, Maghsoudi N, Wood E. PMID: 27115811.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    98. Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials. Addiction. 2016 08; 111(8):1337-46. Singh M, Keer D, Klimas J, Wood E, Werb D. PMID: 26826006.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    99. Risk of violence in drug rehabilitation centers: perceptions of people who inject drugs in Tijuana, Mexico. Subst Abuse Treat Prev Policy. 2016 Jan 26; 11:5. Harvey-Vera AY, González-Zúñiga P, Vargas-Ojeda AC, Medina-Mora ME, Magis-Rodríguez CL, Wagner K, Strathdee SA, Werb D. PMID: 26812913; PMCID: PMC4728769.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    100. Predictors of needle exchange program utilization during its implementation and expansion in Tijuana, Mexico. Am J Addict. 2016 Mar; 25(2):118-24. Smith DM, Werb D, Abramovitz D, Magis-Rodriguez C, Vera A, Patterson TL, Strathdee SA, for Proyecto El Cuete. PMID: 26765073; PMCID: PMC5470727.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    101. The effectiveness of compulsory drug treatment: A systematic review. Int J Drug Policy. 2016 Feb; 28:1-9. Werb D, Kamarulzaman A, Meacham MC, Rafful C, Fischer B, Strathdee SA, Wood E. PMID: 26790691; PMCID: PMC4752879.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    102. Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform. Glob Public Health. 2017 05; 12(5):519-530. Werb D, Strathdee SA, Meza E, Rangel Gomez MG, Palinkas L, Medina-Mora ME, Beletsky L. PMID: 28278755; PMCID: PMC5612664.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    103. Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico. Drug Alcohol Rev. 2015 Nov; 34(6):630-6. Rafful C, Wagner KD, Werb D, González-Zúñiga PE, Verdugo S, Rangel G, Strathdee SA. PMID: 25867795; PMCID: PMC4869533.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    104. Examining the spatial distribution of law enforcement encounters among people who inject drugs after implementation of Mexico's drug policy reform. J Urban Health. 2015 Apr; 92(2):338-51. Gaines TL, Beletsky L, Arredondo J, Werb D, Rangel G, Vera A, Brouwer K. PMID: 25300503; PMCID: PMC4411320.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    105. High dead-space syringe use among people who inject drugs in Tijuana, Mexico. Am J Drug Alcohol Abuse. 2015 May; 41(3):220-5. Rafful C, Zule W, González-Zúñiga PE, Werb D, Medina-Mora ME, Magis-Rodriguez C, Strathdee SA. PMID: 25695145; PMCID: PMC4603554.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    106. Development of a brief substance use sensation seeking scale: validation and prediction of injection-related behaviors. AIDS Behav. 2015 Feb; 19(2):352-61. Werb D, Richardson C, Buxton J, Shoveller J, Wood E, Kerr T. PMID: 25119056; PMCID: PMC4450886.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    107. Police bribery and access to methadone maintenance therapy within the context of drug policy reform in Tijuana, Mexico. Drug Alcohol Depend. 2015 Mar 01; 148:221-5. Werb D, Wagner KD, Beletsky L, Gonzalez-Zuniga P, Rangel G, Strathdee SA. PMID: 25655577; PMCID: PMC4330115.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    108. Mexico's "ley de narcomenudeo" drug policy reform and the international drug control regime. Harm Reduct J. 2014 Nov 14; 11(1):31. Mackey TK, Werb D, Beletsky L, Rangel G, Arredondo J, Strathdee SA. PMID: 25395346; PMCID: PMC4234880.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    109. Mexico's drug policy reform: cutting edge success or crisis in the making? Int J Drug Policy. 2014 Sep; 25(5):823-5. Werb D, Mora ME, Beletsky L, Rafful C, Mackey T, Arredondo J, Strathdee SA. PMID: 24974368; PMCID: PMC4169748.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    110. Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting. CMAJ. 2013 Dec 10; 185(18):1569-75. Werb D, Kerr T, Buxton J, Shoveller J, Richardson C, Montaner J, Wood E. PMID: 24130244; PMCID: PMC3855114.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    111. The temporal relationship between drug supply indicators: an audit of international government surveillance systems. BMJ Open. 2013 Sep 30; 3(9):e003077. Werb D, Kerr T, Nosyk B, Strathdee S, Montaner J, Wood E. PMID: 24080093; PMCID: PMC3787412.
      View in: PubMed   Mentions: 17     Fields:    
    112. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013 Dec 01; 133(2):669-76. Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. PMID: 24055187.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    113. Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting. Drug Alcohol Depend. 2013 Oct 01; 132(3):535-40. Werb D, Kerr T, Buxton J, Shoveller J, Richardson C, Montaner J, Wood E. PMID: 23642315; PMCID: PMC3762907.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. Neighborhood of residence and risk of initiation into injection drug use among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2013 Oct 01; 132(3):486-90. Chami G, Werb D, Feng C, DeBeck K, Kerr T, Wood E. PMID: 23587537; PMCID: PMC3927649.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    115. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav. 2013 Jan; 17(1):68-73. Werb D, Milloy MJ, Kerr T, Zhang R, Montaner J, Wood E. PMID: 22249956; PMCID: PMC4931799.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    116. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy. Int J Drug Policy. 2012 Nov; 23(6):436-41. Werb D, Nosyk B, Kerr T, Fischer B, Montaner J, Wood E. PMID: 23085258.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    117. Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study. Prev Med. 2012 Nov; 55(5):500-4. Hadland SE, Werb D, Kerr T, Fu E, Wang H, Montaner JS, Wood E. PMID: 22954518; PMCID: PMC3489963.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    118. Drug dealing cessation among a cohort of drug users in Vancouver, Canada. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):459-63. Werb D, Bouchard M, Kerr T, Shoveller J, Qi J, Montaner J, Wood E. PMID: 21664770; PMCID: PMC3182286.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    119. The effectiveness of anti-illicit-drug public-service announcements: a systematic review and meta-analysis. J Epidemiol Community Health. 2011 Oct; 65(10):834-40. Werb D, Mills EJ, Debeck K, Kerr T, Montaner JS, Wood E. PMID: 21558482.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    120. Effect of drug law enforcement on drug market violence: a systematic review. Int J Drug Policy. 2011 Mar; 22(2):87-94. Werb D, Rowell G, Guyatt G, Kerr T, Montaner J, Wood E. PMID: 21392957.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    121. Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026. Int J Drug Policy. 2011 Jan; 22(1):70-6. Werb D, Wood E, Kerr T, Hershfield N, Palmer RW, Remis RS. PMID: 21051212.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    122. Vienna Declaration: a call for evidence-based drug policies. Lancet. 2010 Jul 31; 376(9738):310-2. Wood E, Werb D, Kazatchkine M, Kerr T, Hankins C, Gorna R, Nutt D, Des Jarlais D, Barré-Sinoussi F, Montaner J. PMID: 20650517.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    123. Drug-related risks among street youth in two neighborhoods in a Canadian setting. Health Place. 2010 Sep; 16(5):1061-7. Werb D, Kerr T, Fast D, Qi J, Montaner JS, Wood E. PMID: 20621542; PMCID: PMC2920044.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    124. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis. 2010 Jul; 10(7):464-9. Werb D, Mills EJ, Montaner JS, Wood E. PMID: 20610328.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    125. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction. 2010 Jun; 105(6):991-1002. Marshall BD, Werb D. PMID: 20659059.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    126. Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug Alcohol Rev. 2010 May; 29(3):271-7. Werb D, Debeck K, Kerr T, Li K, Montaner J, Wood E. PMID: 20565519; PMCID: PMC4643832.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    127. Cannabis policy: time to move beyond the psychosis debate. Int J Drug Policy. 2010 Jul; 21(4):261-4. Werb D, Fischer B, Wood E. PMID: 20381329.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    128. Methamphetamine use and malnutrition among street-involved youth. Harm Reduct J. 2010 Mar 08; 7:5. Werb D, Kerr T, Zhang R, Montaner JS, Wood E. PMID: 20210992; PMCID: PMC2841129.
      View in: PubMed   Mentions: 10     Fields:    
    129. Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia". Harm Reduct J. 2009 Nov 27; 6:33. Werb D, Wood E. PMID: 19943944; PMCID: PMC2789049.
      View in: PubMed   Mentions:    Fields:    
    130. Drug use patterns among Thai illicit drug injectors amidst increased police presence. Subst Abuse Treat Prev Policy. 2009 Jul 21; 4:16. Werb D, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Lai C, Kerr T. PMID: 19622171; PMCID: PMC2725037.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    131. The war on drugs: a devastating public-policy disaster. Lancet. 2009 Mar 21; 373(9668):989-90. Wood E, Werb D, Marshall BD, Montaner JS, Kerr T. PMID: 19282025.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    132. The need for an evidence-based approach to controlling opium production in Afghanistan. J Public Health Policy. 2008 Dec; 29(4):440-8. Werb D, Kerr T, Montaner J, Wood E. PMID: 19079302.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    133. Effect of methadone treatment on incarceration rates among injection drug users. Eur Addict Res. 2008; 14(3):143-9. Werb D, Kerr T, Marsh D, Li K, Montaner J, Wood E. PMID: 18552490.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    134. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies. J Public Health (Oxf). 2008 Jun; 30(2):126-32. Werb D, Kerr T, Small W, Li K, Montaner J, Wood E. PMID: 18387974.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    135. Risks surrounding drug trade involvement among street-involved youth. Am J Drug Alcohol Abuse. 2008; 34(6):810-20. Werb D, Kerr T, Li K, Montaner J, Wood E. PMID: 19016187.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    136. Nonfatal overdose among a cohort of street-involved youth. J Adolesc Health. 2008 Mar; 42(3):303-6. Werb D, Kerr T, Lai C, Montaner J, Wood E. PMID: 18295139; PMCID: PMC2290001.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    137. Drug treatment courts in Canada: an evidence-based review. HIV AIDS Policy Law Rev. 2007 Dec; 12(2-3):12-7. Werb D, Elliott R, Fischer B, Wood E, Montaner J, Kerr T. PMID: 18459192.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    138. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy. 2008 Aug; 19(4):332-8. Werb D, Wood E, Small W, Strathdee S, Li K, Montaner J, Kerr T. PMID: 17900888; PMCID: PMC2529170.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansPHPublic Health
    Daniel's Networks
    Concepts (265)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (31)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California